Phoenix Biotech Acquisition Corp. (PBAX)
$10.9
+0.05 (+0.00%)
Rating:
Recommendation:
-
| Symbol | PBAX |
|---|---|
| Price | $10.9 |
| Beta | 0.041 |
| Volume Avg. | 0.00M |
| Market Cap | 68.084M |
| Shares () | - |
| 52 Week Range | 10.22-11.83 |
| 1y Target Est | - |
| DCF Unlevered | PBAX DCF -> | |
|---|---|---|
| DCF Levered | PBAX LDCF -> | |
| ROE | 2026.88% | Strong Buy |
| ROA | -28.42% | Sell |
| Operating Margin | - | |
| Debt / Equity | -25.46% | Neutral |
| P/E | -31.14 | Strong Sell |
| P/B | -12.60 | Strong Sell |
About
Download (Excel)Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.